PURE Bioscience, Inc. (OTCMKTS:PURE – Get Free Report) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.07 and traded as high as $0.12. PURE Bioscience shares last traded at $0.10, with a volume of 39,366 shares trading hands.
PURE Bioscience Trading Down 5.9 %
The stock has a 50-day moving average of $0.08 and a two-hundred day moving average of $0.07. The firm has a market cap of $10.64 million, a price-to-earnings ratio of -2.38 and a beta of 0.05.
PURE Bioscience Company Profile
PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.
Featured Articles
- Five stocks we like better than PURE Bioscience
- Differences Between Momentum Investing and Long Term Investing
- Palantir Cracks $50, Is There Still Time to Get on Board?
- How to Find Undervalued Stocks
- Insider Buying Signals Upside for These 3 Stocks
- Upcoming IPO Stock Lockup Period, Explained
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
